Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 5560 | 1541 | 42.7 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | INTERLEUKIN 12 | Author keyword | 78 | 23% | 19% | 299 |
| 2 | IL 12 | Author keyword | 32 | 14% | 14% | 214 |
| 3 | IL 12 RECEPTOR | Author keyword | 12 | 53% | 1% | 16 |
| 4 | INFLAMMAT AUTOIMMUNE DIS | Address | 7 | 42% | 1% | 13 |
| 5 | IL12B | Author keyword | 5 | 40% | 1% | 10 |
| 6 | INTERLEUKIN 12 RECEPTOR | Author keyword | 5 | 38% | 1% | 10 |
| 7 | BOVINE IL 12 | Author keyword | 4 | 75% | 0% | 3 |
| 8 | CHICKEN IL 12 | Author keyword | 3 | 100% | 0% | 3 |
| 9 | INTERLEUKIN 12 P40 | Author keyword | 3 | 50% | 0% | 4 |
| 10 | IL 12R BETA 2 | Author keyword | 3 | 32% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | INTERLEUKIN 12 | 78 | 23% | 19% | 299 | Search INTERLEUKIN+12 | Search INTERLEUKIN+12 |
| 2 | IL 12 | 32 | 14% | 14% | 214 | Search IL+12 | Search IL+12 |
| 3 | IL 12 RECEPTOR | 12 | 53% | 1% | 16 | Search IL+12+RECEPTOR | Search IL+12+RECEPTOR |
| 4 | IL12B | 5 | 40% | 1% | 10 | Search IL12B | Search IL12B |
| 5 | INTERLEUKIN 12 RECEPTOR | 5 | 38% | 1% | 10 | Search INTERLEUKIN+12+RECEPTOR | Search INTERLEUKIN+12+RECEPTOR |
| 6 | BOVINE IL 12 | 4 | 75% | 0% | 3 | Search BOVINE+IL+12 | Search BOVINE+IL+12 |
| 7 | CHICKEN IL 12 | 3 | 100% | 0% | 3 | Search CHICKEN+IL+12 | Search CHICKEN+IL+12 |
| 8 | INTERLEUKIN 12 P40 | 3 | 50% | 0% | 4 | Search INTERLEUKIN+12+P40 | Search INTERLEUKIN+12+P40 |
| 9 | IL 12R BETA 2 | 3 | 32% | 0% | 7 | Search IL+12R+BETA+2 | Search IL+12R+BETA+2 |
| 10 | IL 12B | 2 | 44% | 0% | 4 | Search IL+12B | Search IL+12B |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LYMPHOCYTE MATURATION FACTOR | 214 | 67% | 12% | 192 |
| 2 | CELL STIMULATORY FACTOR | 168 | 46% | 18% | 273 |
| 3 | HETERODIMERIC CYTOKINE | 104 | 60% | 7% | 113 |
| 4 | FACTOR NKSF | 85 | 79% | 4% | 55 |
| 5 | RECOMBINANT HUMAN INTERLEUKIN 12 | 72 | 48% | 7% | 110 |
| 6 | STIMULATORY FACTOR NKSF | 53 | 58% | 4% | 61 |
| 7 | IL 12 RECEPTOR | 44 | 54% | 4% | 56 |
| 8 | IL 12 | 42 | 15% | 17% | 265 |
| 9 | RECOMBINANT IL 12 | 41 | 63% | 3% | 41 |
| 10 | ACTIVATED HUMAN LYMPHOBLASTS | 35 | 86% | 1% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | 2003 | 1924 | 136 | 43% |
| New insights into IL-12-mediated tumor suppression | 2015 | 3 | 154 | 56% |
| The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses | 1998 | 897 | 161 | 55% |
| INTERLEUKIN-12 - A PROINFLAMMATORY CYTOKINE WITH IMMUNOREGULATORY FUNCTIONS THAT BRIDGE INNATE RESISTANCE AND ANTIGEN-SPECIFIC ADAPTIVE IMMUNITY | 1995 | 1901 | 86 | 70% |
| Interleukin-12 in anti-tumor immunity and immunotherapy | 2002 | 363 | 84 | 57% |
| Interleukin-12: Biological properties and clinical application | 2007 | 222 | 93 | 52% |
| IL-12p40: an inherently agonistic cytokine | 2007 | 121 | 61 | 59% |
| Interleukin-12: A cytokine at the interface of inflammation and immunity | 1998 | 584 | 715 | 36% |
| Gene therapy of cancer based on interleukin 12 | 2005 | 55 | 67 | 67% |
| Cancer Electrogene Therapy with Interleukin-12 | 2010 | 26 | 98 | 58% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INFLAMMAT AUTOIMMUNE DIS | 7 | 42% | 0.8% | 13 |
| 2 | ONCOL C6 | 2 | 44% | 0.3% | 4 |
| 3 | THER IE GEN HUMAINE EXPT | 2 | 67% | 0.1% | 2 |
| 4 | UT BIOMED SCI | 2 | 67% | 0.1% | 2 |
| 5 | ANIM MODEL IL | 2 | 26% | 0.3% | 5 |
| 6 | AIRC IMMUNOL TUMORS | 1 | 31% | 0.3% | 4 |
| 7 | BIOL THER IES | 1 | 38% | 0.2% | 3 |
| 8 | HLTH CARE ISOLA | 1 | 50% | 0.1% | 2 |
| 9 | MOL PHARMACOL BIOTECHNOL | 1 | 50% | 0.1% | 2 |
| 10 | RADIAT HEMATOL | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000137731 | IL 27//INTERLEUKIN 27//IL 35 |
| 2 | 0.0000119297 | ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE |
| 3 | 0.0000099077 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
| 4 | 0.0000086517 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
| 5 | 0.0000082809 | INTERLEUKIN 18//IL 18//INTERLEUKIN 18 BINDING PROTEIN |
| 6 | 0.0000065438 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
| 7 | 0.0000055489 | AK 5 TUMOR//MECHANOCHEMICAL POTENTIAL//AK 5 APOPTOSIS |
| 8 | 0.0000053521 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
| 9 | 0.0000053314 | IL 10R1//VIRAL IL 10//INTERLEUKIN 10 RECEPTOR |
| 10 | 0.0000050486 | CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS |